HIGHLIGHTS
- who: August and collaborators from the National Institute of Pharmaceutical Education and Research, Kolkata, India Zhejiang Chinese Medical University have published the research: Puerarin: A protective drug against ischemia-reperfusion injury, in the Journal: (JOURNAL)
- how: The results showed that intermittent infusion of a cardioplegic solution containing puerarin significantly decreased myocardial lactate production during ischemia and myocardial oxygen consumption C.K. release and water content during reperfusion (Fan et_al 1992a). These data indicated that puerarin exerts an anti-inflammatory protective effect on brain tissue with IRI by down-regulating the expression of multiple inflammatory factors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.